Vikas Goyal
Managing Partner at Trekk Venture Partners
Cambridge, Massachusetts
Overview
Work Experience
Managing Partner and Co-Founder
2022 - Current
Trekk is a venture capital firm dedicated to investing in early stage biotech companies developing life-changing medicines.
Trekk Venture Partners is a venture capital company that develops life-changing medicines.
Merck Integration
2021 - 2021
SVP Business Development
2019 - 2021
Board Member
2018 - 2019
Board Member
2016 - 2021
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Raised $510,499,755.00 from Pfizer Venture Investments, Novo Holdings, Invus, Polaris Partners, ShangPharma, Schrödinger, Timothy A. Springer, SR One, Omega Funds and EcoR1 Capital.
Board Member
2018 - 2019
Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.
Raised $637,000,000.00 from Biotechnology Value Fund, RA Capital Management, Gates Frontier Fund, SR One, Pfizer Venture Investments, Bain Capital Life Sciences, Atlas Venture, Google Ventures, SV Health Investors and Lightstone Ventures.
Board Member
2015 - 2019
Board Member
2013 - 2019
Principal
2011 - 2019
Biotech venture capital for novel drug discovery and development companies in Boston and globally.
SR One is the corporate venture capital arm of GlaxoSmithKline.
Board Member
2014 - 2018
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Raised $443,556,000.00 from GlaxoSmithKline, Pfizer, OUP (Osage University Partners) and Cowen Investment Management.
Manager, Corporate Strategy & Development
2010 - 2011
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Raised $538,040,191.00 from Biotechnology Value Fund and Purdue Pharma.